Search

On May 24 the European Commission made a commitment to create a single market for intellectual property rights. In a series of articles we will be looking into the details of this latest initiative, reporting on progress, and assessing outcomes

Biofuels could grow to 9% of global transport fuels by 2030 but getting there will take more research and clear-sighted government policy

The pharmaceutical sector launched a Framework for Action to tackle non-communicable diseases including cardiovascular disease, cancer, diabetes and chronic respiratory diseases that are posing a threat to public health, and public and private finances worldwide.

With around 400,000 students, five of the UK’s top 10 research institutions, and more than 20 Nobel prize winners, London has as much claim to be the centre of the country’s science as Oxford or Cambridge. So why does it have such a hard job holding on to its spin-out companies, particularly in life sciences?

US/European move to put more weight behind moves to improve drug development processes and increase’s R&D productivity in the pharmaceutical industry

It’s widely accepted that intellectual property and equity are essential ingredients for a start-up. But this is not true in every case

The new National Institute for Bioprocessing Research and Training (NIBRT) has been officially opened to support the development of Ireland’s biopharmaceutical sector

Phase 2 of a joint project by the UK and Indian governments has opened with £5 million available to support collaborations

Six new collaborative projects have been funded by the UK Technology Strategy Board to advance personalised medicine in cancer and lay foundations for national adoption

The European Commission has received resounding public backing for its Green Paper proposal to bring research, development and innovation under one umbrella. Now it wants the public to vote on one of three shortlisted names for the new programme

The European Commission’s latest update on its Innovation Union strategy says economic growth targets will not be met unless there is a great leap forward for innovation

A new Science|Business report summarizes the first in a series of three high-level academic policy debates, focused on the energy R&D challenge. Twelve key ideas and recommendations emerged to better leverage Europe's research potential and speed the development of new energy technologies.

The UK quoted technology transfer specialist says investors’ appetite for risk has returned. The new money will allow IP Group to up its stake in portfolio companies and form more new ones